The inclusion of both collagen-binding assays (type III and type VI) in our diagnostic algorithm enhanced the efficacy of the VWD diagnosis and consequently, the identification of the most appropriate management for each patient.
We previously published analyses of average health care expenditures during 2008 for US males with haemophilia. We reported that average annual healthcare expenditures were $100 000 to $155 000 in 2008 US dollars [1, 2] . In this research letter, we report further analyses from the MarketScan â research databases intended to help understand differences in expenditures for those covered by either Medicaid or employer-sponsored insurance (ESI).
Our primary measures of healthcare utilization are proportion of admission, proportion of treat-andrelease ED visits (hereafter referred to as ED visits), length of hospital stays, frequency of ED visits and frequency of non-ED outpatient visits. Length of stay for hospitalizations is determined from admission and discharge dates. ED visits that resulted in hospital admission are recorded as hospitalizations. Outpatient visits are defined as visits based on outpatient claims data, except ED visits and claims filed by laboratories, imaging centres, radiologists, pathologists, pharmacists, supply centres, case managers and home healthcare services.
Propensity score matching method
We use propensity score matching (PSM) technique, which controls for observable differences and assumes that unobservable factors are highly correlated with observable characteristics [3] . Using a logistic regression model, we estimated the propensity score of having Medicaid coverage for all individuals based on a set of observed covariates, without interactions or nonlinear terms. Matching covariates were age, risk score, haemophilia A vs. B, receipt of bypassing agents, and presence of any predefined comorbid conditions (infection with HIV or hepatitis C virus, injury, cardiovascular disease, hypertension, hypercholesterolaemia, chronic arthropathy, diabetes, renal disease, musculoskeletal and connective tissue issues, intracranial haemorrhage, depression, pulmonary disease, neurological disease or liver disease). All persons with Medicaid coverage were then matched to persons with ESI, using the nearest neighbour one-to-one matching technique within a calliper of 0.25 standard deviations of the propensity scores [4] .
Multivariate model
We conducted multivariate analyses using the propensity score-matched sample. To better capture heterogeneous health-seeking behaviours between non-users and users or between less and more extensive users, we used mixture models. To assess the influence of covariates on outpatient visits and annual expenditures, we employed a semi-parametric, latent-class finite mixture model (FMM). Such a model uses observed data on healthcare use to distinguish two population subgroups with less vs. more extensive use of healthcare services [5, 6] . FMM models assign observations into one of two latent classes and estimate both the distribution between classes and the 'effect' of each class on the amount of service used. The latent classes differ for each outcome measure; more extensive users of outpatient services are not necessarily more extensive users of annual healthcare expenditures.
To examine predictors of expenditures for clotting factor obtained through pharmacies and visits to EDs, we also used a two-part model [7, 8] , as well as a zero-inflated negative binomial model for hospitalization. Both models allow zero and positive values of factor expenses from pharmacies and acute care service use. The first part of each predicts factor purchasing activity through pharmacies or acute service use as a dichotomy (none vs. some); the second part predicts their factor expenditures as a continuous variable, or level of acute service use as a count variable conditioned on positive observations.
Results
The final study sample consisted of 419 males with Medicaid and 419 males with ESI who were successfully matched using PSM.
Approximately 54% of the sample had zero ED visits and 83% had no hospitalizations during 2008 (Table 1 ). In contrast, only 3% of the sample had no outpatient visits or zero annual expenditure recorded. Expenditures per ED visit, outpatient visit and inpatient admission among Medicaid enrolees were threeto six-fold lower than among ESI enrolees.
Expenditures per ED visit, outpatient visit and inpatient admission among Medicaid enrolees were threeto six-fold lower than among ESI enrolees (Table 1) . Medicaid enrolees were less than one-half as likely to receive an infusion at home by a health service Table 1 . Descriptive statistics of healthcare expenditures and utilization using the study sample selected after propensity score matching, 2008. provider, and among those who did, average expenditure on clotting factor per infusion was 35% lower (Table 1) . Expenditures per unit of clotting factor purchased from pharmacies, identified by NDC, were the same for Medicaid and ESI enrolees.
Variables associated with healthcare expenditures and utilization
Regression results are shown in Table 2 . In order, dependent variables are (i) total healthcare expenditures; (ii) ratio of persons obtaining factor through pharmacies and these expenditures for factor if any; (iii) number of outpatient visits; (iv) ratio of persons who had at least one ED visit and number of ED visits if any and (v) ratio of persons hospitalized and annual length of stay, if any. The coefficients of the first two rows of each model in Table 2 measure the associations of Medicaid coverage with healthcare expenditures and utilization, relative to employer-sponsored insurance (default), by Medicaid qualification criteria (poverty or disability). Total expenditures differed by Medicaid qualification criteria and level of healthcare use (less vs. more extensive users, see columns 2À3). The FMM identified 87% of the study sample as less extensive users and 13% as more extensive users of overall healthcare resources. Total expenditures of poverty-qualified Medicaid enrolees were lower than those of ESI enrolees, whereas disability-qualified Medicaid enrolees had significantly higher total expenditures.
Medicaid enrolees were more likely to obtain factor through pharmacies, regardless of Medicaid qualification criteria, than ESI enrolees (P < 0.01, see column 4). However, their expenditures for factor differed by Medicaid qualification criteria, compared to those of ESI enrolees (see column 5). The factor expenditures of poverty-qualified Medicaid enrolees among those who had positive pharmacy expenditures were significantly lower than those of ESI enrolees (P < 0.01), whereas those of disability-qualified Medicaid enrolees had a coefficient close to zero, i.e., essentially the same as the ESI group.
The difference in frequency of outpatient visits between Medicaid enrolees and ESI enrolees varied by level of healthcare use (columns 6À7). Among more extensive users, Medicaid enrolees had significantly more frequent outpatient visits than ESI enrolees. In contrast, among less extensive users, there was no significant difference in the frequency of outpatient visits between insurance types.
A higher proportion of poverty-qualified Medicaid enrolees than those with ESI had at least one ED visit (column 8). Among ED users, Medicaid enrolees had more frequent ED visits than those with ESI, regardless of Medicaid eligibility criteria (column 9). The proportion of Medicaid enrolees receiving inpatient The Vuong test compares the zero-inflated model with an ordinary negative binomial model [9] . A significant z-test indicates that the zero-inflated model is better at a 1% level of significance (z = 6.14).
The symbols ***, ** and * indicate a significance level of 1%, 5% and 10%, respectively, for a two-tailed test. Robust standard errors are given in parentheses.
care services was slightly lower, but the difference was not statistically significant (column 10). When disability-qualified Medicaid enrolees were admitted to hospitals, they were likely to stay significantly longer than those with ESI (column 11). Comorbidities such as injury, hypertension, chronic arthropathy, intracranial haemorrhage and depression were significant cost drivers. Injury, intracranial haemorrhage and depression were also associated with increased healthcare utilization, especially more frequent outpatient visits and ED visits and longer hospitalizations. Although other comorbidities such as musculoskeletal, connective tissue and neurological disease were associated with the likelihood and frequency of ED visits and outpatient visits, especially among less extensive users, they were not statistically significant cost drivers. Also, these comorbidities were not associated with use of inpatient care.
Discussion
We found that Medicaid spends less on average than ESI plans for males with haemophilia on a health riskadjusted basis, by an average of $17 277 per person per year, in 2008 dollars. A novel contribution of this study is the use of a latent-class regression model. Such a model can better capture heterogeneous behaviours between less and more extensive users. Lower expenditures associated with Medicaid coverage were concentrated among less extensive users, whose healthcare expenditures were relatively moderate. In contrast, predicted Medicaid spending was higher than ESI spending among extensive users of healthcare services (average expenditures of more than half a million dollars per year).
Slightly lower predicted spending through Medicaid than ESI reflects a combination of marginally higher utilization and much lower average expenditure per service. We found that Medicaid enrolees with haemophilia had (i) more frequent outpatient visits among more extensive users; (ii) higher likelihood of ED visits among poverty-qualified Medicaid enrolees; (iii) more frequent ED visits regardless of Medicaid qualification and (iv) more hospital days among disability-qualified Medicaid enrolees.
Differences in the severity of haemophilia symptoms can explain the observed differences in utilization between the two Medicaid eligibility groups, since the poverty-qualified enrolees showed lower demand for clotting factor and inpatient care. The positive association of poverty-qualified Medicaid coverage with ED use (relative to ESI) is consistent with reports of increases in ED visits among newly insured individuals with Medicaid [10, 11] .
Most of the limitations of this study are inherent in claims data: non-representativeness at the population level, lack of data on socioeconomic status, underascertainment of those with mild symptoms and understatement of expenditures for people with coverage by other insurance plans. We were not able to classify individuals as having severe, moderate or mild haemophilia due to lack of clinical data.
In conclusion, insurance type affected patients' source of factor; healthcare utilization varied by Medicaid qualification criteria and by extensiveness of service use. On average, because of lower reimbursements, Medicaid spent less per person with haemophilia than did ESI plans. However, Medicaid spent more on extensive users than did ESI plans.
